Safety, tolerability and efficacy of peginterferon alpha‐2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial
Article
Witthöft, Th., Möller, B., Wiedmann, K. H., Mauss, St., Link, R., Lohmeyer, J., Lafrenz, M., Gelbmann, C. M., Hüppe, D., Niederau, C. and Alshuth, U. (2007) Safety, tolerability and efficacy of peginterferon alpha‐2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial. Journal of Viral Hepatitis 14 (11), pp. 788-796.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Journal of Viral Hepatitis | ||||
| Publisher | BLACKWELL PUBLISHING | ||||
| Place of Publication | OXFORD | ||||
| Volume | 14 | ||||
| Number of Issue or Book Chapter | 11 | ||||
| Page Range | pp. 788-796 | ||||
| Date | 2007 | ||||
| Date of publication | 19 Dec 2024 13:37 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin I | ||||
| Identification Number |
| ||||
| Keywords | INTERFERON ALPHA-2A; VIRUS-INFECTION; PLUS RIBAVIRIN; NON-A; COMBINATION; THERAPY; hepatitis C; pegylated interferon; polymerase chain reaction; sustained virological response | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 68757 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric